The two data releases coming up are not binary events. Even if another trial is needed, I don’t think it will affect the SP much as only a few are expecting some type of PA, AA, etc.
The second Rett trial will be more binary and will have me a little nervous while waiting.
I will sell some of there is a huge run up before then.
Anyway. When thinking about selling, I always ask myself it anything has changed. If the company has given me no reason to sell, then why would I?
Has the thesis changed? Negative results? Poor management decision? If not, then I stay put.
Market Data 
Markets 
AI
